US Patent 11834445 Polymorphic forms of metopimazine
Patent 11834445 was granted and assigned to Neurogastrx on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+211 characters)
US Patent 11834445 Polymorphic forms of metopimazine
Article
Patent abstract
Provided herein are novel polymorphic forms of metopimazine mesylate. These polymorphic forms are useful in methods, compositions, and kits for the treatment of an enteric nervous system disorder.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Shu Yu0
Date of Patent
December 5, 2023
0Patent Application Number
178360600
Date Filed
June 9, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11834445 Polymorphic forms of metopimazine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
